1572 related articles for article (PubMed ID: 15906230)
1. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma.
Lahav R
Int J Dev Biol; 2005; 49(2-3):173-80. PubMed ID: 15906230
[TBL] [Abstract][Full Text] [Related]
2. Cooperative and indispensable roles of endothelin 3 and KIT signalings in melanocyte development.
Aoki H; Motohashi T; Yoshimura N; Yamazaki H; Yamane T; Panthier JJ; Kunisada T
Dev Dyn; 2005 Jun; 233(2):407-17. PubMed ID: 15768389
[TBL] [Abstract][Full Text] [Related]
3. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo.
Lahav R; Heffner G; Patterson PH
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11496-500. PubMed ID: 10500205
[TBL] [Abstract][Full Text] [Related]
4. Roles of endothelin signaling in melanocyte development and melanoma.
Saldana-Caboverde A; Kos L
Pigment Cell Melanoma Res; 2010 Apr; 23(2):160-70. PubMed ID: 20128875
[TBL] [Abstract][Full Text] [Related]
5. Cell-autonomous and cell non-autonomous signaling through endothelin receptor B during melanocyte development.
Hou L; Pavan WJ; Shin MK; Arnheiter H
Development; 2004 Jul; 131(14):3239-47. PubMed ID: 15201217
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
Lahav R; Suvà ML; Rimoldi D; Patterson PH; Stamenkovic I
Cancer Res; 2004 Dec; 64(24):8945-53. PubMed ID: 15604257
[TBL] [Abstract][Full Text] [Related]
7. Impaired growth and differentiation of diploid but not immortal melanoblasts from endothelin receptor B mutant (piebald) mice.
Sviderskaya EV; Easty DJ; Bennett DC
Dev Dyn; 1998 Dec; 213(4):452-63. PubMed ID: 9853966
[TBL] [Abstract][Full Text] [Related]
8. First-in-Human Proof-of-Concept Study: Intralesional Administration of BQ788, an Endothelin Receptor B Antagonist, to Melanoma Skin Metastases.
Wouters J; Hunger RE; Garrod T; Dubuis B; Hunziker T; van den Oord JJ; Lahav-le Coutre R
Oncologist; 2015 Oct; 20(10):1121-2. PubMed ID: 26330458
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Eberle J; Weitmann S; Thieck O; Pech H; Paul M; Orfanos CE
J Invest Dermatol; 1999 Jun; 112(6):925-32. PubMed ID: 10383740
[TBL] [Abstract][Full Text] [Related]
10. Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes.
Aoki H; Yamada Y; Hara A; Kunisada T
Development; 2009 Aug; 136(15):2511-21. PubMed ID: 19553284
[TBL] [Abstract][Full Text] [Related]
11. Ednrb2 orients cell migration towards the dorsolateral neural crest pathway and promotes melanocyte differentiation.
Pla P; Alberti C; Solov'eva O; Pasdar M; Kunisada T; Larue L
Pigment Cell Res; 2005 Jun; 18(3):181-7. PubMed ID: 15892714
[TBL] [Abstract][Full Text] [Related]
12. Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns.
Yoshida H; Kunisada T; Kusakabe M; Nishikawa S; Nishikawa SI
Development; 1996 Apr; 122(4):1207-14. PubMed ID: 8620847
[TBL] [Abstract][Full Text] [Related]
13. EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling.
Takeo M; Lee W; Rabbani P; Sun Q; Hu H; Lim CH; Manga P; Ito M
Cell Rep; 2016 May; 15(6):1291-302. PubMed ID: 27134165
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 upregulates MCAM in melanocytes.
Mangahas CR; dela Cruz GV; Schneider RJ; Jamal S
J Invest Dermatol; 2004 Dec; 123(6):1135-9. PubMed ID: 15610525
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progression.
Rosanò L; Spinella F; Genovesi G; Di Castro V; Natali PG; Bagnato A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S136-9. PubMed ID: 15838263
[TBL] [Abstract][Full Text] [Related]
16. Removal of stem cell factor or addition of monoclonal anti-c-KIT antibody induces apoptosis in murine melanocyte precursors.
Ito M; Kawa Y; Ono H; Okura M; Baba T; Kubota Y; Nishikawa SI; Mizoguchi M
J Invest Dermatol; 1999 May; 112(5):796-801. PubMed ID: 10233774
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of Kit-independent melanocyte precursors induced in the skin of Steel factor transgenic mice.
Kawaguchi A; Chiba K; Tanimura Y; Motohashi T; Aoki H; Takeda T; Hayashi S; Shimizu K; Kunisada T
Dev Growth Differ; 2008 Feb; 50(2):63-9. PubMed ID: 18067587
[TBL] [Abstract][Full Text] [Related]
18. Review: melanocyte migration and survival controlled by SCF/c-kit expression.
Yoshida H; Kunisada T; Grimm T; Nishimura EK; Nishioka E; Nishikawa SI
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):1-5. PubMed ID: 11764276
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelin receptor type-A and type-B antagonists on prostaglandin F2alpha-induced luteolysis of the sheep corpus luteum.
Doerr MD; Goravanahally MP; Rhinehart JD; Inskeep EK; Flores JA
Biol Reprod; 2008 Apr; 78(4):688-96. PubMed ID: 18077801
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
Montgomery JP; Patterson PH
BMC Cancer; 2008 Nov; 8():354. PubMed ID: 19040731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
